Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PD 1 and PDL 1 expression in primary central nervous system diffuse large B‐cell lymphoma are frequent and expression of PD 1 predicts poor survival

13 Dec 2016

Abstract excerpt

Primary central nervous system diffuse large B-cell lymphoma (PCNS-DLBCL) is a rare and aggressive type of diffuse large B-cell lymphoma (DLBCL) whit poorly understood pathogenesis. Finding biomarkers associated with patient survival may be important for understanding its physiopathology and to develop new therapeutic approaches. We investigated 32 PCNS-DLBCL from immunocompetent patients for BCL2, CMYC, LMO2,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CNS Lymphoma Diagnosis and Treatment
Share to Glioma Diagnosis and Treatment
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27966264
DOI: 10.1002/hon.2375

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PD 1 and PDL 1 expression in primary central nervous system diffuse large B‐cell lymphoma are frequent and expression of PD 1 predicts poor survivalPMID 27966264Read ↗

Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomasSemantic proximity Read ↗

Insights into the biology of primary central nervous system lymphoma.Semantic proximity Read ↗

PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell–inflamed phenotypeSemantic proximity Read ↗

Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas.Semantic proximity Read ↗

Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in TreatmentSemantic proximity Read ↗

MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomasSemantic proximity Read ↗

MYC Protein Expression in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous SystemSemantic proximity Read ↗

PD-1 related transcriptome profile and clinical outcome in diffuse gliomasSemantic proximity Read ↗

Frequent Gene Mutations and Their Possible Roles in the Pathogenesis, Treatment and Prognosis of Primary Central Nervous System Lymphoma.Semantic proximity Read ↗

Primary CNS lymphoma commonly expresses immune response biomarkersSemantic proximity Read ↗

Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomasSemantic proximity Read ↗

Programmed Cell Death 1 and Programmed Cell Death Ligands in Extranodal Natural Killer/T Cell Lymphoma: Expression Pattern and Potential Prognostic RelevanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.